Skip to main content
Aggregate STAT News 生物医药 20 Aug 2026 - 18:30

STAT+: One of the most consequential year for cancer treatment, ever

RSS 官方收录 · 可信分层展示

关键摘要

This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter.STAT+ subscribers can sign up here to get it delivered to their inbox.…

  • Twenty-four hours later, my brain is still whirling over yesterday’s s…
  • I posted this on X yesterday but it’s worth repeating here: Between th…
  • Continue to STAT+ to read the full story…

摘要引擎:抽取

正文提要

This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox.

Twenty-four hours later, my brain is still whirling over yesterday’s stunning news from Merck and Moderna about the success of their personalized mRNA cancer therapy in a melanoma late-stage clinical trial.

I posted this on X yesterday but it’s worth repeating here: Between this spring’s Revolution Medicines success with a KRAS-targeted drug and now Merck and Moderna’s success with an mRNA neoantigen vaccine, 2026 will go down as one of the most consequential years in cancer treatment, ever.

Continue to STAT+ to read the full story…

打开官方原文 站点原文页 可信分区 本信源更多 今日简报 分享图 RSS 稍后再看列表